Invesco Nasdaq Biotechnology ETF (IBBQ)

NASDAQ: IBBQ · IEX Real-Time Price · USD
+0.52 (2.71%)
At close: Oct 4, 2022 3:50 PM
-0.12 (-0.61%)
After-hours: Oct 4, 2022 5:21 PM EDT
Assets $21.84M
NAV $19.16
Expense Ratio 0.19%
PE Ratio 72.45
Shares Out 1.14M
Dividend (ttm) $0.22
Dividend Yield 1.13%
Ex-Dividend Date Sep 19, 2022
1-Year Return -23.82%
Volume 3,171
Open 19.48
Previous Close 19.16
Day's Range 19.48 - 19.68
52-Week Low 16.73
52-Week High 26.15
Beta -1.22
Holdings 365
Inception Date Jun 11, 2021

About IBBQ

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Asset Class Equity
Region North America
Issuer Invesco
Stock Exchange NASDAQ
Ticker Symbol IBBQ
Index Tracked Nasdaq Biotechnology Index

Top 10 Holdings

51.45% of assets
Name Symbol Weight
Gilead Sciences GILD 7.98%
Amgen AMGN 7.70%
Vertex Pharmaceuticals VRTX 7.68%
Regeneron Pharmaceuticals REGN 7.64%
Moderna MRNA 4.79%
Biogen BIIB 4.01%
AstraZeneca AZN 3.46%
Illumina ILMN 3.10%
Seagen SGEN 2.61%
Alnylam Pharmaceuticals ALNY 2.49%
View More Holdings


Ex-Dividend Amount Pay Date
2022-09-19 $0.03769 2022-09-23
2022-06-21 $0.04264 2022-06-30
2022-03-21 $0.03778 2022-03-31
2021-12-20 $0.10511 2021-12-31
2021-09-20 $0.04324 2021-09-30
Full Dividend History


Invesco's Rene Reyna on Biotech's Rally and the Potential for Future Growth

Biotech has had a strong rally since June, when fortune for the sector abruptly pivoted after months of underperformance.   The sector peaked in early 2021 but struggled to continue the momentum, despit...

Other symbols: PBE
1 month ago - ETF Trends

Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its...

Other symbols: BBHGERMMRNA
2 months ago - ETF Trends

Pharma & Biotech ETFs at One-Month High: Here's Why

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

3 months ago - Zacks Investment Research

Pfizer Biohaven Acquisition Sparks Hope of More Biotech M&A

Earlier this week, Pfizer (NYSE:PFE) announced plans to acquire Biohaven Pharmaceutical (NASDAQ:BHVN) for $11.6 billion, sparking hopes of more biotechnology consolidation activity to come. Pfizer is pa...

5 months ago - ETF Trends

Battered Biotech Space Now Unbelievably Inexpensive

After disappointing in 2021, biotechnology stocks and exchange traded funds are getting shellacked this year as growth stocks fall out of favor due to rising interest rates. As experienced biotech inves...

5 months ago - ETF Trends

Biotech ETFs Muddled Despite Amgen Strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buy...

Other symbols: BBHIBB
8 months ago - ETF Trends

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in developm...

Other symbols: BIBBIS
9 months ago - ETF Trends

Biotech Firms Partner to Advance Therapeutic Medicine

Although biotechnology stocks have been lackluster for the past year, the industry is gaining increased attention of late, not just for the role it's played in combatting the COVID-19 pandemic, but also...

9 months ago - ETF Trends

An ETF to Capture Promising Biotech Innovators

Innovative biotechnology companies are coming out with novel treatments in the healthcare industry. Investors can also capture the ongoing innovations in the biotech sector through a targeted exchange t...

9 months ago - ETF Trends

Biotech Stocks and ETFs Can Get Their Grooves Back

As is now widely documented, biotechnology stocks and exchange traded funds endured a rough 2021. Compounding those woes is the fact that investors were caught off guard by last year's lethargy because ...

9 months ago - ETF Trends

Expect More Biotech Consolidation Activity in 2022

The biotechnology industry is often a hotbed of mergers and acquisitions speculation. Announced deals are a different matter altogether.

10 months ago - ETF Trends

Moderna's Omicron Booster Strategy Lifts Biotechnology ETFs

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechn...

Other symbols: IBB
11 months ago - ETF Trends

Position for Biotech Rebound With Quality Names

Broadly speaking, 2021 hasn't been kind to biotechnology stocks and exchange traded funds, but some market participants remain optimistic regarding a rebound for these previously beloved assets. One way...

1 year ago - ETF Trends

An ETF to Watch for Amidst the Vaccine Push

While Covid-19 variants on the rise, the push for more vaccinations make the Invesco Nasdaq Biotechnology ETF (IBBQ) an ETF to watch. As Covid cases experience a resurgence, more companies are mandating...

1 year ago - ETF Trends

New Biotechnology ETF Could Be a Stellar Second Half Idea

The Invesco Nasdaq Biotechnology ETF (IBBQ) is just a few weeks old, but even with that rookie status, it could be a stellar second half idea. On the back of the Food and Drug Administration (FDA) condi...

1 year ago - ETF Trends

A Biotech ETF to Track Nasdaq's Industry-Setting Benchmark

As investors consider the regulatory, scientific, and demographic factors driving today's growth in biotechnology industry, they can look to the Nasdaq Biotechnology Index's methodology and one related ...

1 year ago - ETF Trends

The Biotech Trek: A Short History from 1993 to 2021

The Nasdaq Biotechnology Index (NBI) launched in 1993, when the industry was still in the midst of the original “biotech revolution.” Since then, its constituent basket has swelled from roughly 100 comp...

1 year ago - ETF Trends